Literature DB >> 15845798

Image-guided tumor ablation: standardization of terminology and reporting criteria.

S Nahum Goldberg1, Clement J Grassi, John F Cardella, J William Charboneau, Gerald D Dodd, Damian E Dupuy, Debra Gervais, Alice R Gillams, Robert A Kane, Fred T Lee, Tito Livraghi, John McGahan, David A Phillips, Hyunchul Rhim, Stuart G Silverman.   

Abstract

The field of interventional oncology with use of image-guided tumor ablation requires standardization of terminology and reporting criteria to facilitate effective communication of ideas and appropriate comparison between treatments that use different technologies, such as chemical (ethanol or acetic acid) ablation, and thermal therapies, such as radiofrequency, laser, microwave, ultrasound, and cryoablation. This document provides a framework that will hopefully facilitate the clearest communication between investigators and will provide the greatest flexibility in comparison between the many new, exciting, and emerging technologies. An appropriate vehicle for reporting the various aspects of image-guided ablation therapy, including classification of therapies and procedure terms, appropriate descriptors of imaging guidance, and terminology to define imaging and pathologic findings, are outlined. Methods for standardizing the reporting of follow-up findings and complications and other important aspects that require attention when reporting clinical results are addressed. It is the group's intention that adherence to the recommendations will facilitate achievement of the group's main objective: improved precision and communication in this field that lead to more accurate comparison of technologies and results and, ultimately, to improved patient outcomes. Copyright RSNA, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 15845798      PMCID: PMC3406173          DOI: 10.1148/radiol.2353042205

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  90 in total

1.  Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation.

Authors:  John R Leyendecker; Gerald D Dodd; Glenn A Halff; Victor A McCoy; Dacia H Napier; Linda G Hubbard; Kedar N Chintapalli; Shailendra Chopra; W Kenneth Washburn; Robert M Esterl; Francisco G Cigarroa; Ruth E Kohlmeier; Francis E Sharkey
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

2.  Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues.

Authors:  I S COPPER
Journal:  N Engl J Med       Date:  1963-04-04       Impact factor: 91.245

3.  Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system.

Authors:  J S Lewin; C A Petersilge; S F Hatem; J L Duerk; G Lenz; M E Clampitt; M L Williams; K R Kaczynski; C F Lanzieri; A L Wise; J R Haaga
Journal:  AJR Am J Roentgenol       Date:  1998-06       Impact factor: 3.959

4.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

5.  Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.

Authors:  Eren Berber; Nora Flesher; Allan E Siperstein
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

Review 6.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 7.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 8.  Chemoembolization of hepatocellular carcinoma.

Authors:  Douglas E Ramsey; Lily Y Kernagis; Michael C Soulen; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2002-09       Impact factor: 3.464

9.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  152 in total

1.  CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.

Authors:  Constantinos T Sofocleous; Elena N Petre; Mithat Gonen; Karen T Brown; Stephen B Solomon; Anne M Covey; William Alago; Lynn A Brody; Raymond H Thornton; Michael D'Angelica; Yuman Fong; Nancy E Kemeny
Journal:  J Vasc Interv Radiol       Date:  2011-04-22       Impact factor: 3.464

2.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

3.  Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation.

Authors:  Y Li; G Shi; S Wang; S Wang; R Wu
Journal:  Br J Radiol       Date:  2013-07-24       Impact factor: 3.039

4.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

5.  Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results.

Authors:  Bruno Caspani; Anna Maria Ierardi; Fabio Motta; Piero Cecconi; Edoardo Fesce; Luca Belli
Journal:  Eur Radiol       Date:  2010-03-25       Impact factor: 5.315

6.  Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution.

Authors:  V Arienti; S Pretolani
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

7.  Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.

Authors:  Dong Ho Lee; Jeong Min Lee; Mi Hye Yu; Bo Yun Hur; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Jung-Hwan Yoon; Yoon Jun Kim; Jeong-Hoon Lee; Su Jong Yu; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-01-14       Impact factor: 5.315

Review 8.  Imaging Features following Thermal Ablation of Lung Malignancies.

Authors:  Sophie Chheang; Feredoin Abtin; Antonio Guteirrez; Scott Genshaft; Robert Suh
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

9.  [Metastases of colorectal carcinoma].

Authors:  S Clasen; H Rempp; P L Pereira
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

10.  Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.

Authors:  David A Kunkle; Robert G Uzzo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.